• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病中肝活检与影像学方法的评估:阿姆斯特丹非酒精性脂肪性肝病-非酒精性脂肪性肝炎队列。

Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD-NASH Cohort.

机构信息

Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands.

Department of Internal and Vascular Medicine, Amsterdam University Medical Centres, Amsterdam, The Netherlands.

出版信息

J Magn Reson Imaging. 2021 Dec;54(6):1937-1949. doi: 10.1002/jmri.27703. Epub 2021 May 15.

DOI:10.1002/jmri.27703
PMID:33991378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9290703/
Abstract

BACKGROUND

Noninvasive diagnostic methods are urgently required in disease stratification and monitoring in nonalcoholic fatty liver disease (NAFLD). Multiparametric magnetic resonance imaging (MRI) is a promising technique to assess hepatic steatosis, inflammation, and fibrosis, potentially enabling noninvasive identification of individuals with active and advanced stages of NAFLD.

PURPOSE

To examine the diagnostic performance of multiparametric MRI for the assessment of disease severity along the NAFLD disease spectrum with comparison to histological scores.

STUDY TYPE

Prospective, cohort.

POPULATION

Thirty-seven patients with NAFLD.

FIELD STRENGTH/SEQUENCE: Multiparametric MRI at 3.0 T consisted of magnetic resonance (MR) spectroscopy (MRS) with multi-echo stimulated-echo acquisition mode, magnitude-based and three-point Dixon using a two-dimensional multi-echo gradient echo, MR elastography (MRE) using a generalized multishot gradient-recalled echo sequence and intravoxel incoherent motion (IVIM) using a multislice diffusion weighted single-shot echo-planar sequence.

ASSESSMENT

Histological steatosis grades were compared to proton density fat fraction measured by MRS (PDFF ), magnitude-based MRI (PDFF ), and three-point Dixon (PDFF ), as well as FibroScan® controlled attenuation parameter (CAP). Fibrosis and disease activity were compared to IVIM and MRE. FibroScan® liver stiffness measurements were compared to fibrosis levels. Diagnostic performance of all imaging parameters was determined for distinction between simple steatosis and nonalcoholic steatohepatitis (NASH).

STATISTICAL TESTS

Spearman's rank test, Kruskal-Wallis test, Dunn's post-hoc test with Holm-Bonferroni P-value adjustment, receiver operating characteristic curve analysis. A P-value <0.05 was considered statistically significant.

RESULTS

Histological steatosis grade correlated significantly with PDFF (r  = 0.66, P < 0.001), PDFF (r  = 0.68, P < 0.001), and PDFF (r  = 0.67, P < 0.001), whereas no correlation was found with CAP. MRE and IVIM diffusion and perfusion significantly correlated with disease activity (r  = 0.55, P < 0.001, r  = -0.40, P = 0.016, r  = -0.37, P = 0.027, respectively) and fibrosis (r  = 0.55, P < 0.001, r  = -0.46, P = 0.0051; r  = -0.53, P < 0.001, respectively). MRE and IVIM diffusion had the highest area-under-the-curve for distinction between simple steatosis and NASH (0.79 and 0.73, respectively).

DATA CONCLUSION

Multiparametric MRI is a promising method for noninvasive, accurate, and sensitive distinction between simple hepatic steatosis and NASH, as well as for the assessment of steatosis and fibrosis severity.

LEVEL OF EVIDENCE

2 TECHNICAL EFFICACY: 2.

摘要

背景

非酒精性脂肪性肝病(NAFLD)的疾病分层和监测迫切需要非侵入性诊断方法。多参数磁共振成像(MRI)是一种评估肝脂肪变性、炎症和纤维化的有前途的技术,有可能实现对具有活跃和晚期 NAFLD 的个体的非侵入性识别。

目的

通过与组织学评分相比,检查多参数 MRI 评估 NAFLD 疾病谱中疾病严重程度的诊断性能。

研究类型

前瞻性、队列研究。

人群

37 例 NAFLD 患者。

磁场强度/序列:3.0T 多参数 MRI 包括磁共振波谱(MRS)多回波激发回波采集模式、基于幅度的和三点 Dixon 使用二维多回波梯度回波、使用广义多shot 梯度回波序列的磁共振弹性成像(MRE)和使用多切片扩散加权单次激发回波平面序列的体素内不相干运动(IVIM)。

评估

组织学脂肪变性等级与质子密度脂肪分数(MRS 测量的 PDFF)、基于幅度的 MRI(PDFF)和三点 Dixon(PDFF)以及 FibroScan®受控衰减参数(CAP)进行比较。纤维化和疾病活动与 IVIM 和 MRE 进行比较。FibroScan®肝硬度测量与纤维化水平进行比较。确定所有成像参数的诊断性能,以区分单纯性脂肪变性和非酒精性脂肪性肝炎(NASH)。

统计检验

Spearman 秩检验、Kruskal-Wallis 检验、Dunn 事后检验与 Holm-Bonferroni P 值调整、受试者工作特征曲线分析。P 值<0.05 被认为具有统计学意义。

结果

组织学脂肪变性等级与 PDFF(r = 0.66,P<0.001)、PDFF(r = 0.68,P<0.001)和 PDFF(r = 0.67,P<0.001)显著相关,而与 CAP 无相关性。MRE 和 IVIM 扩散和灌注与疾病活动(r = 0.55,P<0.001,r = -0.40,P = 0.016,r = -0.37,P = 0.027)和纤维化(r = 0.55,P<0.001,r = -0.46,P = 0.0051;r = -0.53,P<0.001)显著相关。MRE 和 IVIM 扩散在区分单纯性脂肪变性和 NASH 方面具有最高的曲线下面积(0.79 和 0.73)。

数据结论

多参数 MRI 是一种有前途的非侵入性、准确和敏感的方法,可用于区分单纯性肝脂肪变性和 NASH,以及评估脂肪变性和纤维化的严重程度。

证据水平

2 技术功效:2.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fa3/9290703/87c072f9f57f/JMRI-54-1937-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fa3/9290703/b00be031ab9f/JMRI-54-1937-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fa3/9290703/70f46e58c1a7/JMRI-54-1937-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fa3/9290703/6f7819b1703c/JMRI-54-1937-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fa3/9290703/87c072f9f57f/JMRI-54-1937-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fa3/9290703/b00be031ab9f/JMRI-54-1937-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fa3/9290703/70f46e58c1a7/JMRI-54-1937-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fa3/9290703/6f7819b1703c/JMRI-54-1937-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fa3/9290703/87c072f9f57f/JMRI-54-1937-g002.jpg

相似文献

1
Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD-NASH Cohort.非酒精性脂肪性肝病中肝活检与影像学方法的评估:阿姆斯特丹非酒精性脂肪性肝病-非酒精性脂肪性肝炎队列。
J Magn Reson Imaging. 2021 Dec;54(6):1937-1949. doi: 10.1002/jmri.27703. Epub 2021 May 15.
2
The Combination of MR Elastography and Proton Density Fat Fraction Improves Diagnosis of Nonalcoholic Steatohepatitis.磁共振弹性成像联合质子密度脂肪分数对非酒精性脂肪性肝炎的诊断价值。
J Magn Reson Imaging. 2022 Aug;56(2):368-379. doi: 10.1002/jmri.28040. Epub 2021 Dec 25.
3
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.磁共振弹性成像与瞬时弹性成像在经活检证实的非酒精性脂肪性肝病患者纤维化检测及脂肪变性无创测量中的比较
Gastroenterology. 2017 Feb;152(3):598-607.e2. doi: 10.1053/j.gastro.2016.10.026. Epub 2016 Oct 27.
4
Visco-Elastic Parameters at Three-Dimensional MR Elastography for Diagnosing Non-Alcoholic Steatohepatitis and Substantial Fibrosis in Mice.三维磁共振弹性成像的粘弹性参数用于诊断小鼠非酒精性脂肪性肝炎和显著肝纤维化
J Magn Reson Imaging. 2024 Jan;59(1):97-107. doi: 10.1002/jmri.28765. Epub 2023 May 9.
5
Automated Analysis of Multiparametric Magnetic Resonance Imaging/Magnetic Resonance Elastography Exams for Prediction of Nonalcoholic Steatohepatitis.多参数磁共振成像/磁共振弹性成像检查的自动分析用于预测非酒精性脂肪性肝炎。
J Magn Reson Imaging. 2021 Jul;54(1):122-131. doi: 10.1002/jmri.27549. Epub 2021 Feb 15.
6
Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time.肝脏丙氨酸可将人类和小鼠的非酒精性脂肪性肝炎与单纯性脂肪变性区分开来:质子磁共振波谱研究与长回波时间。
J Magn Reson Imaging. 2017 Nov;46(5):1298-1310. doi: 10.1002/jmri.25673. Epub 2017 Feb 22.
7
Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort.定量多参数磁共振成像有助于日本队列中的非酒精性脂肪性肝炎诊断。
World J Gastroenterol. 2021 Feb 21;27(7):609-623. doi: 10.3748/wjg.v27.i7.609.
8
Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease.多参数磁共振指数在非酒精性脂肪性肝病患者非酒精性肝炎诊断中的应用。
Sci Rep. 2020 Feb 14;10(1):2671. doi: 10.1038/s41598-020-59601-3.
9
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.磁共振成像比瞬时弹性成像更能准确地对非酒精性脂肪性肝病患者的脂肪变性和纤维化进行分类。
Gastroenterology. 2016 Mar;150(3):626-637.e7. doi: 10.1053/j.gastro.2015.11.048. Epub 2015 Dec 8.
10
Prospective Evaluation of Virtual MR Elastography With Diffusion-Weighted Imaging in Subjects With Nonalcoholic Fatty Liver Disease.前瞻性评估弥散加权成像虚拟磁共振弹性成像在非酒精性脂肪性肝病患者中的应用。
J Magn Reson Imaging. 2022 Nov;56(5):1448-1456. doi: 10.1002/jmri.28154. Epub 2022 Mar 14.

引用本文的文献

1
Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives.代谢功能障碍相关脂肪性肝病患者的肝脏硬度测量:方法有效性及前景的最新进展
World J Hepatol. 2025 Jul 27;17(7):106675. doi: 10.4254/wjh.v17.i7.106675.
2
Comparing FIB-4, VCTE, pSWE, 2D-SWE, and MRE Thresholds and Diagnostic Accuracies for Detecting Hepatic Fibrosis in Patients with MASLD: A Systematic Review and Meta-Analysis.比较FIB-4、VCTE、pSWE、二维剪切波弹性成像(2D-SWE)和磁共振弹性成像(MRE)在检测代谢相关脂肪性肝病(MASLD)患者肝纤维化中的阈值及诊断准确性:一项系统评价和荟萃分析
Diagnostics (Basel). 2025 Jun 24;15(13):1598. doi: 10.3390/diagnostics15131598.
3

本文引用的文献

1
Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort.定量多参数磁共振成像有助于日本队列中的非酒精性脂肪性肝炎诊断。
World J Gastroenterol. 2021 Feb 21;27(7):609-623. doi: 10.3748/wjg.v27.i7.609.
2
Automated Analysis of Multiparametric Magnetic Resonance Imaging/Magnetic Resonance Elastography Exams for Prediction of Nonalcoholic Steatohepatitis.多参数磁共振成像/磁共振弹性成像检查的自动分析用于预测非酒精性脂肪性肝炎。
J Magn Reson Imaging. 2021 Jul;54(1):122-131. doi: 10.1002/jmri.27549. Epub 2021 Feb 15.
3
A composite biomarker using multiparametric magnetic resonance imaging and blood analytes accurately identifies patients with non-alcoholic steatohepatitis and significant fibrosis.
Liver Fat Fraction and Machine Learning Improve Steatohepatitis Diagnosis in Liver Transplant Patients.
肝脏脂肪分数与机器学习改善肝移植患者的脂肪性肝炎诊断
NMR Biomed. 2025 Jul;38(7):e70077. doi: 10.1002/nbm.70077.
4
Visceral adiposity index as a predictor of metabolic dysfunction-associated steatotic liver disease: a cross-sectional study.内脏脂肪指数作为代谢功能障碍相关脂肪性肝病的预测指标:一项横断面研究。
BMC Gastroenterol. 2025 May 1;25(1):326. doi: 10.1186/s12876-025-03957-1.
5
Ketogenic Diet in Steatotic Liver Disease: A Metabolic Approach to Hepatic Health.生酮饮食在脂肪性肝病中的应用:一种维护肝脏健康的代谢方法。
Nutrients. 2025 Apr 4;17(7):1269. doi: 10.3390/nu17071269.
6
Randomised double-blind placebo-controlled trial protocol to evaluate the therapeutic efficacy of lyophilised faecal microbiota capsules amended with next-generation beneficial bacteria in individuals with metabolic dysfunction-associated steatohepatitis.评估冻干粪便微生物群胶囊添加新一代有益细菌对代谢功能障碍相关脂肪性肝炎患者治疗效果的随机双盲安慰剂对照试验方案
BMJ Open. 2025 Jan 9;15(1):e088290. doi: 10.1136/bmjopen-2024-088290.
7
Head-to-head comparison among FAST, MAST, and multiparametric MRI-based new score in diagnosing at-risk MASH.在诊断高危非酒精性脂肪性肝炎方面,FAST、MAST与基于多参数磁共振成像的新评分之间的直接比较。
Eur Radiol. 2025 Jun;35(6):3599-3609. doi: 10.1007/s00330-024-11215-3. Epub 2024 Dec 5.
8
Exploring the epidemiology and awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among health sciences students in an academic health care institute in India.探索印度一所学术医疗保健机构中健康科学专业学生代谢功能障碍相关脂肪性肝病(MASLD)的流行病学及认知情况。
Metabol Open. 2024 Oct 18;24:100325. doi: 10.1016/j.metop.2024.100325. eCollection 2024 Dec.
9
Effect of a multidisciplinary lifestyle intervention on body composition in people with osteoarthritis: Secondary analysis of the "Plants for Joints" randomized controlled trial.多学科生活方式干预对骨关节炎患者身体成分的影响:“关节植物疗法”随机对照试验的二次分析
Osteoarthr Cartil Open. 2024 Oct 1;6(4):100524. doi: 10.1016/j.ocarto.2024.100524. eCollection 2024 Dec.
10
Accuracy of Non-Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD: A Systematic Review.非侵入性成像技术对代谢相关脂肪性肝病(MASLD)患者诊断代谢相关脂肪性肝炎(MASH)的准确性:一项系统评价
Liver Int. 2025 Apr;45(4):e16127. doi: 10.1111/liv.16127. Epub 2024 Oct 14.
一种使用多参数磁共振成像和血液分析物的复合生物标志物能准确识别非酒精性脂肪性肝炎和显著纤维化患者。
Sci Rep. 2020 Sep 17;10(1):15308. doi: 10.1038/s41598-020-71995-8.
4
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.纤维化分期与非酒精性脂肪性肝病患者结局的相关性:系统评价和荟萃分析。
Gastroenterology. 2020 May;158(6):1611-1625.e12. doi: 10.1053/j.gastro.2020.01.043. Epub 2020 Feb 4.
5
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. FibroScan-AST (FAST) 评分用于无创识别有显著活动度和纤维化的非酒精性脂肪性肝炎患者:一项前瞻性推导和全球验证研究。
Lancet Gastroenterol Hepatol. 2020 Apr;5(4):362-373. doi: 10.1016/S2468-1253(19)30383-8. Epub 2020 Feb 3.
6
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.肝纤维化无创诊断技术评估非酒精性脂肪性肝病患者肝脏脂肪变及纤维化的准确性。
Gastroenterology. 2019 May;156(6):1717-1730. doi: 10.1053/j.gastro.2019.01.042. Epub 2019 Jan 25.
7
A novel magnetic resonance elastography transducer concept based on a rotational eccentric mass: preliminary experiences with the gravitational transducer.一种基于旋转偏心质量的新型磁共振弹性成像换能器概念:重力换能器的初步经验。
Phys Med Biol. 2019 Feb 6;64(4):045007. doi: 10.1088/1361-6560/aaf9f8.
8
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.全球视角下的非酒精性脂肪性肝病和非酒精性脂肪性肝炎。
Hepatology. 2019 Jun;69(6):2672-2682. doi: 10.1002/hep.30251.
9
Rheological determinants for simultaneous staging of hepatic fibrosis and inflammation in patients with chronic liver disease.慢性肝病患者肝纤维化和炎症同时分期的流变学决定因素
NMR Biomed. 2018 Oct;31(10):e3956. doi: 10.1002/nbm.3956. Epub 2018 Jul 30.
10
Evaluation of Six Diffusion-weighted MRI Models for Assessing Effects of Neoadjuvant Chemoradiation in Pancreatic Cancer Patients.评估六种扩散加权 MRI 模型在评估新辅助放化疗治疗胰腺癌患者效果中的作用。
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1052-1062. doi: 10.1016/j.ijrobp.2018.04.064. Epub 2018 May 4.